Live Breaking News & Updates on Jurisdictional Drug Development

Stay updated with breaking news from Jurisdictional drug development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Humanigen Announces Participation and Presentation at Multiple Conferences in May

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ announced today that management will present and participate at multiple investors conferences in May 2022. Details of the conferences are as follows: ....

City Of , United Kingdom , Cameron Durrant , Tim Morris , Nj Humanigen Inc , World Congress On , Humanigen Inc , World Congress , Jurisdictional Drug Development , Multi Jurisdictional Drug Development , Host Disease , Forward Looking Statement , Medical Specialties , Us Securities And Exchange Commission , Branches Of Biology , Clinical Medicine , Covid 19 , Granulocyte Macrophage Colony Stimulating Factor , Inflammatory Cytokine , Monoclonal Antibodies ,